Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
International Journal of Molecular Sciences|August 7, 2021
Analysis and Fine Specificity of the HCMV-Specific Cell-Free and Cell-Associated Antibody-Dependent Cellular Phagocytosis (ADCP) Responses in Lung Transplant RecipientsSimone Eberhard, Hannes Vietzen, Irene Görzer, et al.
Transplantation|August 21, 2024
Mechanistic Understanding of EBV+Lymphoproliferative Disease Development After TransplantationPhilippe L Furlano, Georg A Böhmig, Elisabeth Puchhammer-Stöckl, et al.
The Journal of Infectious Diseases|December 9, 2017
NKG2C Deletion Is a Risk Factor for Human Cytomegalovirus Viremia and Disease After Lung TransplantationHannes Vietzen, Karin Pollak, Claudia Honsig, et al.
Journal of Medical Virology|October 21, 2025
Distinct NK Cell Genetic Variants Are Associated With HSV-2 Versus VZV Infection of the CNSMarianne Graninger, Laura Maria Kühner, Sarah Maria Berger, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 27, 2021
Deletion of the NKG2C receptor encoding KLRC2 gene and HLA-E variants are risk factors for severe COVID-19Hannes Vietzen, Alexander Zoufaly, Marianna Traugott, et al.
Blood|December 8, 2022
HLA-E-restricted immune responses are crucial for the control of EBV infections and the prevention of PTLDHannes Vietzen, Philippe L Furlano, Jan J Cornelissen, et al.
Cancer Treatment and Research Communications|March 3, 2025
Influence of histopathological changes after neoadjuvant chemotherapy on the survival of breast cancer patientsSabine Danzinger, Verena Heiss Spornberger, Hannes Vietzen, et al.
Journal of Medical Virology|December 14, 2022
The natural killer cell-associated rs9916629-C allele is a novel genetic risk factor for fatal COVID-19Hannes Vietzen, Philippe L Furlano, Marianna Traugott, et al.
Journal of Innate Immunity|May 25, 2026
Association of CD32-131H>R Polymorphism with End-Stage COPD and Interstitial Lung DiseasesSarah M Berger, Laura M Kühner, Ines M Schwarzinger, et al.
Cell|December 13, 2023
Ineffective control of Epstein-Barr-virus-induced autoimmunity increases the risk for multiple sclerosisHannes Vietzen, Sarah M Berger, Laura M Kühner, et al.
Pageof 4